BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Treatment
24 results:

  • 1. Molecular Screening in Anaplastic lymphoma Kinase-Positive Anaplastic Large Cell lymphoma: Anaplastic lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
    Heger JM; Mattlener J; Schneider J; Gödel P; Sieg N; Ullrich F; Lewis R; Bucaciuc-Mracica T; Schwarz RF; Rueß D; Ruge MI; Montesinos-Rongen M; Deckert M; Blau T; Kutsch N; Balke-Want H; Weiss J; Becker K; Reinhardt HC; Hallek M; Borchmann P; von Tresckow B; Borchmann S
    Blood; 2024 Feb; 143(6):522-534. PubMed ID: 37946299
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acquired resistance to crizotinib in novel CDK14-ALK and cltc-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing.
    Xia Y; Zhang L; He W; Pan H; Fang J; Cui G
    Cancer Biol Ther; 2023 Dec; 24(1):2271212. PubMed ID: 37906510
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
    Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN
    BMC Cancer; 2022 Sep; 22(1):985. PubMed ID: 36109702
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pediatric Non-Myofibroblastic Primitive Spindle Cell Tumors with
    Rakheja D; Park JY; Fernandes NJ; Watt TC; Laetsch TW; Collins RRJ
    Int J Surg Pathol; 2022 Sep; 30(6):706-715. PubMed ID: 35164578
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring.
    Bernasconi DP; Antolini L; Rossi E; Blanco-Lopez JG; Galimberti S; Andersen PK; Valsecchi MG
    Int J Epidemiol; 2022 Feb; 51(1):314-323. PubMed ID: 34368848
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
    Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
    Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
    Kharfan-Dabaja MA; Komrokji RS; Zhang Q; Kumar A; Tsalatsanis A; Perkins J; Nishihori T; Field T; Al Ali N; Mishra A; Sallman D; Salem KZ; Zhang L; Moscinski L; Fernandez HF; Lancet J; List A; Anasetti C; Padron E
    Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):753-758. PubMed ID: 28687222
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [A clinical study of fungal esophagitis in 13 patients with hematologic malignancies].
    Zhou YL; Wei XD; Mi RH; Ai H; Zhang LN; Liu YY; Li YF; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):507-11. PubMed ID: 27431077
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
    Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
    Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular alterations in non-small cell lung carcinomas of the young.
    VandenBussche CJ; Illei PB; Lin MT; Ettinger DS; Maleki Z
    Hum Pathol; 2014 Dec; 45(12):2379-87. PubMed ID: 25288236
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ALK-positive inflammatory myofibroblastic tumor of the abdomen with widespread microscopic multifocality.
    Lorenzi L; Cigognetti M; Medicina D; Pellegrini V; Balzarini P; Cestari R; Facchetti F
    Int J Surg Pathol; 2014 Oct; 22(7):640-4. PubMed ID: 24583837
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.
    Minopetrou M; Hadziyannis E; Deutsch M; Tampaki M; Georgiadou A; Dimopoulou E; Vassilopoulos D; Koskinas J
    Clin Vaccine Immunol; 2013 May; 20(5):698-703. PubMed ID: 23467778
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ALK-positive extramedullary plasmacytoma with expression of the cltc-ALK fusion transcript.
    Wang WY; Gu L; Liu WP; Li GD; Liu HJ; Ma ZG
    Pathol Res Pract; 2011 Sep; 207(9):587-91. PubMed ID: 21855232
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A phase II multicenter clinical trial of systemic bexarotene in psoriasis.
    Smit JV; Franssen ME; de Jong EM; Lambert J; Roseeuw DI; De Weert J; Yocum RC; Stevens VJ; van De Kerkhof PC
    J Am Acad Dermatol; 2004 Aug; 51(2):249-56. PubMed ID: 15280844
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
    Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
    Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mucormycosis in hematologic malignancies: an emerging fungal infection.
    Nosari A; Oreste P; Montillo M; Carrafiello G; Draisci M; Muti G; Molteni A; Morra E
    Haematologica; 2000 Oct; 85(10):1068-71. PubMed ID: 11025599
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
    von Wasielewski R; Seth S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A
    Blood; 2000 Feb; 95(4):1207-13. PubMed ID: 10666192
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
    Larson RA; Fretzin MH; Dodge RK; Schiffer CA
    Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.